Increasing COVID-19 Testing in Chicago's African American Testing Desserts

NCT05197452 | Completed Results

• 2 other identifiers: 20110407R01NR018463
• Study Type: interventional
• Target: 2,167
• Locations: 1 country
• Sites: 1

Brief Summary

This study uses a population-based approach to increase uptake of COVID-19 testing within a highly segregated and underserved African American community in Chicago.

Conditions

COVID-19 Pandemic

Outcome Measures

Primary Outcomes (1)

• COVID-19 Testing Uptake

  Covid testing uptake was measured as the number of neighborhood residents (i.e., count of unique participants) tested for COVID-19 at any timepoint during the study which occurred between December 2020 and August 2022. The were 397 testing events at churches or community site where participants could be tested during this time period. Individuals may have been tested more than once but were only counted once. Testing uptake was assessed as the number of participants tested at least once (n=2167). Pre and post evaluations were not performed. The measure was based a single count of participants tested.

  Up to 20 months

Other Outcomes (2)

• Re-AIM Framework

  Up to 6 months after end of study

• Needs Assessment

  First 2 months of the study prior to the start of the testing intervention

Study Arms (1)

COVID-19 Testing

EXPERIMENTAL

COVID-19 antigen and PCR Testing

Behavioral: COVID-19 Testing

Interventions

COVID-19 Testing BEHAVIORAL

For in-person PCR testing, a nasal swab will be inserted shallowly into the participant's nose and rotated in each nostril. The swab will be broken off into a designated test tube and placed into a specimen bag along with a label. All specimens will be stored in a cooler until they are transported the Rush Laboratory for COVID-19 analysis. For at home antigen testing, participants will download an app to their mobile phone and watch an informational video. The test will be self-administered by inserting a nasal swab into the nostril until a cap containing the swab touches the nose; rubbing the swab tip around the nose cavity 3 times; removing the swab and repeating in the other nostril. The nasal swab, a dropper, processing fluid, and a blue tooth connected analyzer are provided with the testing kit to analyze the sample for COVID-19. COVID-19 home test results are displayed on the participants smart phone after 15 minutes.

COVID-19 Testing

Eligibility Criteria

• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

• All individuals who request a COVID-19 test, including pregnant women and children of all ages

You may not qualify if:

• Individuals who have tested positive for Covid-19 in the prior 3 months

Sponsors & Collaborators

• Rush University Medical Center: lead
• National Institute of Nursing Research (NINR): collaborator

Study Sites (1)

Rush University Medical Center

Chicago, Illinois, 60422, United States

Location

MeSH Terms

Conditions

COVID-19

Interventions

COVID-19 Testing

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Clinical Laboratory Techniques; Diagnostic Techniques and Procedures; Diagnosis; Investigative Techniques

Results Point of Contact

• Title: Dr. Yolanda Cartwright
• Organization: Research Manager

yolanda_cartwright@rush.edu

224-420-0323

Study Officials

• Elizabeth Lynch, PhD

  Rush University Medical Center

  PRINCIPAL INVESTIGATOR

Publication Agreements

• PI is Sponsor Employee: Yes

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Model Details: We established a network of testing sites in African American churches and community sites located in testing deserts in Chicago. Individuals of all ages were eligible for testing. Individuals with a confirmed COVID-19 infection within the past 3 months were ineligible. Testing was open to the public and no appointments were necessary. Testing was offered 5 days per week (at 1 or 2 locations each day) with varying hours of operation to accommodate community member's work and school schedules. There was no limit to the number of times an individual could be tested. Testing was administered by experienced mobile clinical teams of community health workers and registered nurses from Rush University Medical Center. Participants received COVID-19 education, social determinants of health screening, and free SARS-CoV-2 polymerase chain reaction (PCR) testing.

Study Record Dates

• First Submitted: January 13, 2022
• First Posted: January 19, 2022
• Study Start: March 23, 2021
• Primary Completion: November 18, 2022
• Study Completion: November 18, 2022
• Last Updated: May 24, 2024
• Results First Posted: May 24, 2024

Record last verified: 2024-05

Data Sharing

• IPD Sharing: Will not share

Locations

US (1)